• 519 - Dr Juho Jalkanen on a Promising New Investigational Drug - Bexmarilimab

  • Dec 5 2024
  • Length: 8 mins
  • Podcast

519 - Dr Juho Jalkanen on a Promising New Investigational Drug - Bexmarilimab

Listen for free

View show details

  • Summary

  • Adam Cox is joined by Dr Juho Jalkanen, the CEO of Faron Pharmaceuticals. They discuss a groundbreaking development for cancer treatment, a promising new drug is set to enter late-stage clinical trials here in the UK. Bexmarilimab offers hope to the millions of people suffering from various deadly forms of blood cancer and leukaemia worldwide – where current treatment options are largely failing.

    https://www.faron.com/

    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 519 - Dr Juho Jalkanen on a Promising New Investigational Drug - Bexmarilimab

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available